ISSN 2415-1297 (Online)   ISSN 2415-1300 (Print)
 
             
 
Volume : 25 Issue : 2 Year : 2017
 
Topical 0.05% Cyclosporine A Eyedrops for Treating Moderate-to-Severe Vernal Keratoconjunctivitis [Med J Islamic World Acad Sci]
Med J Islamic World Acad Sci. 2016; 24(4): 107-111 | DOI: 10.5505/ias.2016.83704  

Topical 0.05% Cyclosporine A Eyedrops for Treating Moderate-to-Severe Vernal Keratoconjunctivitis

Kenan Çalışır1, Taha Ayyıldız2, Ümit Çallı3
1Department of Ophthalmology, Horosan Public Hospital, Erzurum, Turkey.
2Department of Ophthalmology, Oltu Public Hospital, Erzurum, Turkey.
3Department of Ophthalmology, Umraniye Training and Research Hospital, İstanbul, Turkey.

This study aimed to investigate the efficacy of topical cyclosporine A (CsA) 0.05% in patients with moderate-to-severe vernal keratoconjunctivitis (VKC).
This retrospective study included 37 patients who were admitted to the clinic between January 2015 and December 2015. All patients were diagnosed with moderate-to-severe VKC and treated with topical CsA 0.05% (Restasis Allergan, Inc. CA, USA). The VKC diagnosis was based on patient history and typical clinical signs and symptoms. Sign and symptom scores of each patient were obtained at pretreatment and during treatment (1, 3, and 6 months).
Of the 37 patients, 20 (54.1%) were male and 17 (45.9%) were female. The mean age of the patients was 11.83 ± 4.70 years (6–24 years). The symptom–sign and total scores of the patients were significantly reduced at 1, 3, and 6 months compared with baseline values. Symptom–sign scores also significantly reduced from 1 month to 3 months and from 3 months to 6 months (P < 0.05).
Topical CsA 0.05% is an effective formulation used for treating moderate-to-severe VKC. It may reduce the need for steroids.

Keywords: Cyclosporine A, topical, vernal keratoconjunctivitis


Kenan Çalışır, Taha Ayyıldız, Ümit Çallı. Topical 0.05% Cyclosporine A Eyedrops for Treating Moderate-to-Severe Vernal Keratoconjunctivitis. Med J Islamic World Acad Sci. 2016; 24(4): 107-111

Corresponding Author: Taha Ayyıldız, Türkiye


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar




 











 
Copyright © 2017 medicaljournal-ias.org. All Rights Reserved.